Table 5.

Risk Adjusted Progression

	OR	95% CI	p
BIS (BMI, p = 0.288)	0.36	0.14–0.88	0.017
BIS (cancer stage, p = 0.002)	0.35	0.13–0.90	0.022
BIS (mastectomy, p = 0.298)	0.36	0.14–0.88	0.014
BIS (ALND, p < 0.001)	0.36	0.14–0.92	0.021
BIS (# nodes removed, p = 0.002)	0.35	0.14–0.90	0.029
BIS (# positive nodes, p = 0.061)	0.36	0.14–0.89	0.023
BIS (any positive nodes, p = 0.009)	0.39	0.15–0.96	0.022
BIS (any chemo, p = 0.002)	0.35	0.13–0.86	0.018
BIS (if chemo, taxane, N = 103, p = 0.276)	0.31	0.10–0.92	0.024
BIS (any radiation, p = 0.330)	0.36	0.14–0.90	0.019
BIS (if radiation, RNI, N = 171, p = 0.098)	0.23	0.07–0.71	0.009
BIS (high risk Tx combination, p = 0.031)	0.37	0.15–0.93	0.023

Bootstrapped bias-corrected parameter estimates (OR), CIs, and p-values for effect of BIS (compared to TM) on the likelihood of progression to CDP after adjusting for the effect of each of the specified known risks for progression. Each of the risks and the probability of their effect on progression that was controlled for in each analysis are shown in ().

CDP, complex decongestive physiotherapy; OR, odds ratio.